March 14, 2025
Edited By: Deepa Varma TOPLINE: Mohs micrographic surgery (MMS) outperforms conventional excision (CE) in patients with hand and foot melanomas, a retrospective cohort study finds. METHODOLOGY: […]
March 13, 2025
ORLANDO, Fla. — The interleukin (IL)-4 and IL-13 inhibitor dupilumab improved itch symptoms and curtailed disease activity while also reducing oral corticosteroid use in older patients […]
March 13, 2025
TOPLINE: Shared inflammatory signatures in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome, myelodysplasia cutis (MDS-cutis), and Sweet syndrome (SS) suggest interferon pathways as therapeutic targets. […]
March 12, 2025
TOPLINE: Chronic cutaneous immune-related adverse events (cirAEs) that develop after immune checkpoint inhibitor (ICI) therapy may require long-term follow-up. METHODOLOGY: A cohort study of 318 patients […]
March 12, 2025
ORLANDO, Fla. — First deployed in the United Kingdom’s National Health Service (NHS) in 2020, an artificial intelligence (AI)-based evaluation of dermatoscope images was found in […]
March 12, 2025
ORLANDO, FLA. — Janus kinase (JAK) inhibitors have revolutionized the treatment of alopecia areata (AA), and more drugs in this class are still in development for […]
March 10, 2025
ORLANDO, Fla. — Whether primary or secondary, delusional infestations (DI), a condition known by many names, can be effectively treated with a step-by-step process based on […]
March 9, 2025
ORLANDO, Fla. — Up to half of all people with severe chronic hand eczema (CHE) who apply delgocitinib cream (Anzupgo) to their hands twice a day […]
March 9, 2025
ORLANDO, Fla. — Cosmetics retailers have significantly stepped up their marketing of skin care products to tweens, teens, and even preadolescents — a trend that a […]